SBFM
Sunshine Biopharma, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.14
+2.70%Aug 31, 2026, 13:00 UTC
Health Canada approved Sunshine Biopharma's generic Atenolol tablets (25mg, 50mg, 100mg) for the Canadian market to treat and manage cardiovascular conditions.
Source:Aug 28, 2026, 20:20 UTC
Dr. Andrew Keller departed as director of Sunshine Biopharma Inc. upon expiry of his term.
Aug 4, 2026, 12:31 UTC
Sunshine Biopharma Inc. received regulatory approval to launch its 2mg generic Dienogest tablets in Canada.
Source:Jul 28, 2026, 12:00 UTC
Health Canada approved Sunshine Biopharma's generic Ondansetron tablets for the Canadian market.
Source: